semaglutide cardiovascular outcomes news 2025 october SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with Weight-loss drug tied to lower

Judicial Panel on Multidistrict Litigation (JPML) to transfer claims brought throughout the federal court system to the U.S

Listening to Your Body Here's the most important thing: your body will tell you what works and what doesn't

It builds on previously published research which found the drug had "consistent benefits" on preventing heart attacks, strokes, and death due to cardiovascular causes in those with type 2 diabetes and chronic kidney disease

This directly and significantly lowers the production of pro-inflammatory cytokines like Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-), effectively cooling the systemic inflammatory fire that drives chronic illness symptoms

Plasma homocysteine and menopausal status

The 9-step facial process turns routine skincare into a calming self-care experience